Germany introduces HPV vacc, Italy to follow
The German government's advisory body, the Standing Commission for Vaccination at the Robert Koch-Institut, has recommended that 12 to 17-year old girls should be immunized against human papillomavirus. Boys would be exempt from the program, despite being potential carriers of the virus, which can trigger cervical cancer.
The Italian Health Ministry is reported to have advised that 12-year-old girls should be vaccinated against HPV, but the go-head is not expected to take effect until regional vaccination centers are prepared.
UK-based drug giant GlaxoSmithKline's Cervarix is not yet licensed for use in the European Union, leaving the field open, in the meantime, to the USA's Merck & Co and France's Sanofi Pasteur, which jointly market Gardasil (Marketletters passim). The vaccine offers protection against HPV types 16 and 18, responsible for 70% of cervical cancers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze